Optimizing fluoroquinolone utilization in a public hospital: A prospective study of educational intervention

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 1, 2005, Pages 6-11

  Lacombe, K ^a   Cariou, S ^a   Tilleul, P ^a   Offenstadt, G ^a   Meynard, J L ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG COST; DRUG UTILIZATION; EDUCATION PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MULTIDRUG RESISTANCE; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; FEMALE; FLUOROQUINOLONES; HOSPITALS, PUBLIC; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROBABILITY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 13144275239     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1246-x     Document Type: Article

References (25)

1. Anonymous (2002) Principes de mise en œuvre d'une démarche qualité en établissement de santé. Rapport Avril 2002. Agence Nationale d'Accréditation et d'Evaluation en Santé, Paris
2. Guthrie R (2002) Community-acquired lower respiratory tract infections - etiology and treatment. Chest 120:2021-2034
3. Garau J, Xercavins M, Rodriguez-Caballeira M, Gomez-Vera JR, Coll I, Vidal D, Llovet T et al (1999) Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 43:2736-2741
4. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523
5. Goldstein FW, Acar JF (1995) Epidemiology of quinolone resistance: Europe and North and South America. Drugs 49(Suppl 2):36-42
6. Mouton Y, Bignolas G, Chidiac C (1995) Recommandations sur la prise en charge de la pathologie infectieuse respiratoire. Med Mal Inf 25:1021-1028
7. Société de Pathologie Infectieuse de Langue Francaise (1991) Antibiothérapie des infections urinaires. Med Mal Inf 21:51-54
8. Erwin WG (1991) The definition of drug utilization review: statement of issues. Clin Pharmacol Ther 50:596-599
9. Edwards AL (1985) Multiple regression and analysis of variance and covariance. W.H. Freeman, New York
10. Zwar N, Wolk J, Gordon J, Sanson-Fisher R, Kerhoe L (1999) Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Fam Pract 16:495-500
11. Zhang L, Li XZ, Poole K (2000) Multiple resistance Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother 44:287-293
12. Robert R, Grollier G, Dore P, Hira M, Ferrand E, Fauchere JL (1999) Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome. J Crit Care 14:114-119
13. Williams JH Jr (2001) Fluoroquinolones for respiratory infections: too valuable to overuse. Chest 120:1771-1775
14. Clark LC, Davis CW (2000) Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pnenumonia. Am J Health Syst Pharm 57(Suppl 3):S10-S13
15. Glemaud I (2000) Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion. Am J Health Syst Pharm 57(Suppl 3):S14-S16
16. Mangione-Smith R, Elliott MN, McDonald L, McGlynn EA (2002) An observational study of antibiotic prescribing behavior and the Hawthorne effect. Health Serv Res 37:1603-1623
17. Erickson CK, Wilcox RE, Miller GW, Littlefield JH, Lawson KA (2003) Effectiveness of addiction science presentations to treatment professionals, using a modified Solomon study design. J Drug Educ 33:197-216
18. Grimshaw JM, Russell IT (1993) Effects of guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317-1322
19. Weingarten SR, Riedenger MS, Hobson P, Noah MS, Johnson B, Giugliano G, Norian J et al (1996) Evaluation of a pneumonia practice guideline in an intervention trial. Am J Respir Crit Care Med 153:1110-1115
20. Whiting-O'Keefe QE, Henke E, Simborg DW (1984) Choosing the correct unit of analysis in medical care experiment. Med Care 22:1101-1114
21. Grimshaw J, Freemantle N, Wallace S, Russell I, Hurwitz B, Watt I, Long A et al (1995) Developing and implementing clinical practice guidelines. Qual Health Care 4:55-64
22. Solomon DH, Hashimoto H, Daltroy L, Liang MH (1998) Techniques to improve physicians' use of diagnostic tests. JAMA 280:2020-2027
23. Phelps CE (1993) The methodologic foundations of studies of appropriateness of medical care. N Engl Med J 329:1241-1245
24. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N et al (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233-1237
25. White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB (1997) Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 25:230-239